ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.

CYCCP Cyclacel Pharmaceuticals Inc

6.30
0.00 (0.00%)
시간외 단일가
최종 업데이트: 17:00:00
15분 지연
기업명 주식 심볼 시장 주식 타입
Cyclacel Pharmaceuticals Inc CYCCP 나스닥 우선주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.00 0.00% 6.30 17:00:00
개장가 저가 고가 종가 전일 종가
6.30
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
14/05/202413:15EDGAR2Form EFFECT - Notice of Effectiveness
14/05/202405:05EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
08/05/202422:15GLOBECyclacel Pharmaceuticals to Release First Quarter 2024..
08/05/202410:53EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
08/05/202410:52EDGAR2Form DEF 14A - Other definitive proxy statements
07/05/202406:26EDGAR2Form S-1 - General form for registration of securities under..
03/05/202405:30GLOBECyclacel Pharmaceuticals Announces Closing of $8.0 Million..
01/05/202402:51APS$8 Million Private Placement Announcement Sends Biotech..
30/04/202420:00GLOBECyclacel Pharmaceuticals Announces $8.0 Million Private..
01/04/202422:15GLOBECyclacel Pharmaceuticals to Present New Clinical Data at..
20/03/202405:05GLOBECyclacel Pharmaceuticals Reports Fourth Quarter and Full..
14/03/202405:05GLOBECyclacel Pharmaceuticals to Release Fourth Quarter and Full..
07/03/202423:15GLOBECyclacel Pharmaceuticals Announces Preclinical..
06/03/202423:15GLOBECyclacel Pharmaceuticals Announces Receipt of $2.9 Million..
20/02/202423:15GLOBECyclacel Pharmaceuticals to Participate in 2024 BIO CEO &..
15/02/202406:31EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
15/02/202406:06EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
15/02/202400:09EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/02/202405:47EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
08/02/202407:03EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
01/02/202406:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/01/202423:15EDGAR2Form 8-K - Current report
30/01/202423:15GLOBECyclacel Pharmaceuticals Announces the Appointment of Brian..
20/01/202406:58EDGAR2Form S-1 - General form for registration of securities under..
13/01/202406:05EDGAR2Form 8-K - Current report
11/01/202403:35EDGAR2Form SC 13G - Statement of acquisition of beneficial..
05/01/202406:30EDGAR2Form SC 13G - Statement of acquisition of beneficial..
05/01/202406:05EDGAR2Form 8-K - Current report
27/12/202306:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/12/202306:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/12/202323:29EDGAR2Form 8-K - Current report
26/12/202323:28EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
18/12/202323:00GLOBECyclacel Pharmaceuticals Reports Fadraciclib Phase 1 Data..
13/12/202306:06EDGAR2Form 8-K - Current report
13/12/202306:05GLOBECyclacel Pharmaceuticals Announces Reverse Stock Split
30/11/202323:15GLOBECyclacel Regains Compliance With Nasdaq Listing Rule..
29/11/202311:31EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
29/11/202311:20EDGAR2Form 10-K/A - Annual report [Section 13 and 15(d), not S-K..
29/11/202307:15GLOBECyclacel Receives Notification of Deficiency From Nasdaq..
29/11/202306:59EDGAR2Form 8-K - Current report
16/11/202307:04EDGAR2Form NT 10-Q - Notification of inability to timely file Form..
16/11/202307:03EDGAR2Form 8-K - Current report
14/11/202306:06EDGAR2Form 8-K - Current report
08/11/202306:10EDGAR2Form 8-K - Current report
07/11/202323:15GLOBECyclacel Pharmaceuticals to Release Third Quarter 2023..
03/11/202305:30EDGAR2Form PRE 14A - Other preliminary proxy statements
09/09/202305:10EDGAR2Form 8-K - Current report
02/09/202306:12EDGAR2Form S-3 - Registration statement under Securities Act of..
11/08/202305:59EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/08/202305:05EDGAR2Form 8-K - Current report

최근 히스토리

Delayed Upgrade Clock